Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Radaelli, Stefano
Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Stefano Radaelli
Favorite
Ragbir, Maniram
The Newcastle upon Tyne NHS Hospitals Foundation Trust
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Maniram Ragbir
Favorite
Rai, Kunal
The University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Kunal Rai
Favorite
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Kunal Rai
Favorite
Ramtohul, Toulsie
Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Toulsie Ramtohul
Favorite
Randall, Lor
University of California, Davis/Orthopaedic Surgery
Paper 31 - ENGINEERED BONE MARROW: A COMPLEX MODEL FOR PRIMARY OSTEOSARCOMA TUMORIGENESIS
Lor Randall
Favorite
Rangan, Amar
University of York
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Amar Rangan
Favorite
Rankin, Kenneth
North of England Bone and Soft Tissue Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust and Translational and Clinical Research Institute, Newcastle University, UK
Paper 70 - SARCOSIGHT: A RANDOMIZED-CONTROL TRIAL OF FLUORESCENCE GUIDED SARCOMA SURGERY VERSUS THE STANDARD OF CARE
Kenneth Rankin
Favorite
Rastogi, Sameer
TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Sameer Rastogi
Favorite
Rastrelli, Marco
Istituto Oncologico Veneto - IOV
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Marco Rastrelli
Favorite
Ratan, Ravin
The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
Ravin Ratan
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Ravin Ratan
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Ravin Ratan
Favorite
Raut, Chandrajit
Brigham and Women’s Hospital/Harvard Medical School
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Chandrajit Raut
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Chandrajit Raut
Favorite
Rawal, Bhupendra
Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Bhupendra Rawal
Favorite
Ray-Coquard, Isabelle
Department of Medical Oncology, Centre Léon Bérard,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Isabelle Ray-Coquard
Favorite
Raymond, Daniel
Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Daniel Raymond
Favorite
Raza, Shaan
MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Shaan Raza
Favorite
Reddy, Vishruth
University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Vishruth Reddy
Favorite
Reed, Damon
Moffitt Cancer Center
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Damon Reed
Favorite
Paper 91 - FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Damon Reed
Favorite
Reichardt, Peter
Helios Klinikum Berlin-Buch
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Peter Reichardt
Favorite
Reijers, Sophie
Nederlands Cancer Institute
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Sophie Reijers
Favorite
Reinecke, James
Nationwide Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
James Reinecke
Favorite
Reinke, Denise
University of Michigan Comprehensive Cancer Center
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Denise Reinke
Favorite
Reith, John
Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
John Reith
Favorite
Rekhi:, Bharat
Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Bharat Rekhi:
Favorite
Rerko, Matthew
Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Matthew Rerko
Favorite
Restrepo Lopez, Juliana
Clínica Vida Fundación and Clínica de Oncología Astorga
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Juliana Restrepo Lopez
Favorite
Rickard, Rory
University Hospital Plymouth NHS Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Rory Rickard
Favorite
Riedel, Richard
Duke Cancer Institute, Duke University Medical Center
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Richard Riedel
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Richard Riedel
Favorite
Rippe, Karsten
Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Karsten Rippe
Favorite
Roberts, James
University College London Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
James Roberts
Favorite
Robertson-Tessi, Mark
Moffitt Cancer Center
Paper 06 - EVOLUTIONARY TUMOR BOARD (NCT04343365) AS A MODEL FOR MOVING FORWARD: METASTATIC EWING SARCOMA
Mark Robertson-Tessi
Favorite
Roberts, Ryan
Division of Hematology and Oncology, Nationwide Children’s Hospital, Department of Pediatrics, The Ohio State University Wexner College of Medicine
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Ryan Roberts
Favorite
Robinson, Steven
Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Steven Robinson
Favorite
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Steven Robinson
Favorite
Roelands, Jessica
Department of Pathology, LUMC
Paper 54 - A MULTI-OMICS APPROACH TO EXPLORE THE PROGNOSTIC IMPACT OF CANCER IMMUNITY IN CHORDOMAS
Jessica Roelands
Favorite
Roggin, Kevin
University of Chicago
Paper 83 - DEVELOPMENT OF A PROGNOSTIC NOMOGRAM TO PREDICT 30-DAY READMISSION IN LOCALIZED SOFT TISSUE SARCOMAS OF THE EXTREMITY
Kevin Roggin
Favorite
Roland, Christina
University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Christina Roland
Favorite
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Christina Roland
Favorite
Rompou, Vaia
The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Vaia Rompou
Favorite
Rose, Brandon
University of Miami/Sylvester Comprehensive Cancer Center
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
Brandon Rose
Favorite
Rosenthal, Katherine
Agenus
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Katherine Rosenthal
Favorite
Rose, Peter
Mayo Clinic
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Peter Rose
Favorite
Roshal, Anna
Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Anna Roshal
Favorite
Roszik, Jason
The University of Texas MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Jason Roszik
Favorite
Roulstone, Victoria
Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Victoria Roulstone
Favorite
Rubin, Brian
Cleveland Clinic
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Brian Rubin
Favorite
Rubino, Franco
MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Franco Rubino
Favorite
Rullan, Antonio
Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Antonio Rullan
Favorite
Rushing, Daniel
Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Daniel Rushing
Favorite
Rutkowski, Piotr
Department of Soft Tissue/Bone Sarcoma and Melanoma; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Piotr Rutkowski
Favorite
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Piotr Rutkowski
Favorite
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Piotr Rutkowski
Favorite
Rutkowski, Piotr
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Piotr Rutkowski
Favorite
Ryan, Christopher
Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Christopher Ryan
Favorite
Back to Top
